Dr. Lui Franciosi reports
VERITAS RECEIVES LISTING ON THE XETRA (FRANKFURT, GERMANY) TRADING VENUE
Veritas Pharma Inc.'s common shares, as of Dec. 7, 2016, are accepted for continuous trading on the electronic trading platform Xetra on the Frankfurt Exchange under the symbol 2VP. Veritas Pharma's
management expects that a listing through Xetra
will provide higher liquidity and more efficient market pricing for the company's common shares.
Veritas chief executive officer Dr. Lui Franciosi stated: "This is a very exciting development and we are proud to be accepted for trading on the Xetra
platform. Xetra
is a more senior European trading venue, and I believe that this will be an important step in introducing our company to a wider range of qualified retail and institutional investors."
© 2024 Canjex Publishing Ltd. All rights reserved.